Company K Partners Valuation Multiples

Discover Company K Partners' revenue and EBITDA valuation multiples and investment history, alongside public comparables like LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment and more.

Company K Partners Overview

About Company K Partners

Company K Partners Ltd is a South Korea based venture capital company involved in partnering with entrepreneurs to deliver market-transforming value in new industrial frontiers. The portfolio of investments of the company include Equity investment in the sectors of Internet, Mobile, Software, Healthcare and Project Investment.


Founded

2006

HQ

South Korea

Employees

N/A

Sectors

Financials (FY)

Revenue: $15M
EBITDA: $7M

EV

$63M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Company K Partners Financials

Company K Partners reported last fiscal year revenue of $15M and EBITDA of $7M.

In the same fiscal year, Company K Partners generated $13M in gross profit, $7M in EBITDA, and $5M in net income.


Company K Partners P&L

In the most recent fiscal year, Company K Partners reported revenue of $15M and EBITDA of $7M.

Company K Partners is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.

See analyst estimates for Company K Partners
Last FY202320242025202620272028
Revenue$15M$11M$11M$15M
Gross Profit$13M$949K$7M$13M
Gross Margin85%8%67%85%
EBITDA$7M($3M)$3M$7M
EBITDA Margin48%(29%)25%48%
EBIT Margin45%(31%)22%45%
Net Profit$5M($4M)$1M$5M
Net Margin34%(36%)14%34%

Financial data powered by Morningstar, Inc.

Company K Partners Stock Performance

Company K Partners has current market cap of $69M, and enterprise value of $63M.

Market Cap Evolution


Company K Partners' stock price is $4.41.

Company K Partners share price increased by 9.0% in the last 30 days, and by 6.7% in the last year.

Company K Partners has an EPS (earnings per share) of $0.33.

See more trading valuation data for Company K Partners
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$63M$69M1.1%9.0%-16.9%6.7%$0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Company K Partners Valuation Multiples

Company K Partners trades at 4.1x EV/Revenue multiple, and 8.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Company K Partners

Company K Partners Financial Valuation Multiples

As of August 9, 2026, Company K Partners has market cap of $69M and EV of $63M.

Company K Partners has a P/E ratio of 13.4x.

Last FY202320242025202620272028
EV/Revenue4.1x5.6x5.9x4.1x
EV/EBITDA8.6x(19.5x)23.4x8.6x
EV/EBIT9.1x(17.9x)27.2x9.1x
EV/Gross Profit4.8x66.4x8.7x4.8x
P/E13.4x(17.0x)46.4x13.4x
EV/FCF22.2x11.0x26.1x22.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Company K Partners Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Company K Partners Margins & Growth Rates

In the most recent fiscal year, Company K Partners reported gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.

See estimated margins and future growth rates for Company K Partners

Company K Partners Margins

Last FY20242025202720282029
Gross Margin85%67%85%
EBITDA Margin48%25%48%
EBIT Margin45%22%45%
Net Margin34%14%34%
FCF Margin18%23%18%

Company K Partners Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(5%)43%
Gross Profit Growth660%82%
EBITDA Growth(183%)173%
EBIT Growth(166%)200%
Net Profit Growth(137%)246%
FCF Growth(58%)17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Company K Partners Operational KPIs

Access forward-looking KPIs for Company K Partners
Last FY202320242025202620272028
S&M Expenses to Revenue6%6%8%6%
G&A Expenses to Revenue2%2%3%2%
Opex to Revenue40%40%46%40%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Company K Partners Competitors

Company K Partners competitors include LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment, Atinum Investment, Alpha, Stonebridge Ventures, DY, Agronomics and SBI Investment KOREA.

Most Company K Partners public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
LB Investment2.7x-7.0x-
Quest for Growth(36.9x)---
Brookfield Glb Infr Secs8.5x---
SV Investment5.2x-(61.9x)-
Atinum Investment0.9x-1.8x-
Alpha0.3x0.3x3.8x-
Stonebridge Ventures2.4x-4.2x-
DY0.1x-1.9x-

This data is available for Pro users. Sign up to see all Company K Partners competitors and their valuation data.

Start Free Trial

Investments by Company K Partners

Company K Partners has invested in 109 companies to date.

Latest investment by Company K Partners was on July 22nd 2026. Company K Partners invested in Prazer Therapeutics in their $32M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Company K Partners

Prazer Therapeutics
EtherNafusion
XCENA
WIRobotics
Description
Prazer Therapeutics is a biotechnology firm developing treatments for intractable diseases using rational molecular drug design and next-generation protein degradation technologies. Based in South Korea, the company focuses on targeted therapies for oncology and rare genetic disorders, leveraging proprietary platforms to engineer protein degraders that selectively eliminate disease-causing proteins. Prazer collaborates with academic institutions and advances candidates through preclinical stages toward clinical trials.
EtherNafusion is a South Korean technology startup that develops small-scale modular fusion reactors.
XCENA is a startup designing intelligent memory and memory-centric computing architectures utilizing CXL technology. The company targets high-performance data processing advancements for data centers and AI applications.
WIRobotics is a wearable robotics company in Cambridge, Massachusetts, developing exosuits to reduce physical strain. Its devices assist workers in manufacturing and logistics, cutting injury rates by 30 percent. WIRobotics pilots with Amazon warehouses. Founded in 2019, it raised $10 million for commercialization.
HQ CountrySouth KoreaSouth KoreaSouth KoreaSouth Korea
HQ City
Seoul
Seoul
Seongnam
Yongin
Deal Date22 Jul 20265 Jul 202628 May 202614 May 2026
RoundUndisclosed stageSeedSeries BSeries B
Raised$32M$2M$135M$65M
InvestorsWoori Venture Partners; Smilegate Investment; Playground Global; Premier Partners; K2 Investment Partners; Company K Partners; Johnson & Johnson InnovationSeoul Techno Holdings; Bluepoint; Company K PartnersKDB Capital; STIC Ventures; IMM Investment; Korea Development Bank; Kiwoom Investment; SV Investment; K2 Investment Partners; Kyobo Securities; Company K Partners; Partners Investment; Atinum Investment; SBI Investment KOREAHana Ventures; Smilegate Investment; SBVA; NH Investment & Securities; InterVest Co.; GU Equity Partners; Company K Partners; JB Investment; FuturePlay
Valuationundisclosedundisclosed$570Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Company K Partners investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Company K Partners

When was Company K Partners founded?Company K Partners was founded in 2006.
Where is Company K Partners headquartered?Company K Partners is headquartered in South Korea.
Is Company K Partners publicly listed?Yes, Company K Partners is a public company listed on Korea Exchange.
What is the stock symbol of Company K Partners?Company K Partners trades under 307930 ticker.
When did Company K Partners go public?Company K Partners went public in 2019.
Who are competitors of Company K Partners?Company K Partners main competitors include LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment, Atinum Investment, Alpha, Stonebridge Ventures, DY, Agronomics, SBI Investment KOREA.
What is the current market cap of Company K Partners?Company K Partners' current market cap is $69M.
What is the current revenue of Company K Partners?Company K Partners' last fiscal year revenue is $15M.
What is the current EV/Revenue multiple of Company K Partners?Current revenue multiple of Company K Partners is 4.1x.
Is Company K Partners profitable?No, Company K Partners is not profitable.
How many companies Company K Partners has acquired to date?Company K Partners hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Company K Partners has invested to date?As of August 2026, Company K Partners has invested in 109 companies.
What was the last Company K Partners investment?On 22nd July 2026 Company K Partners invested in Prazer Therapeutics, participating in a $32M Undisclosed stage round, alongside Woori Venture Partners, Smilegate Investment, Playground Global, Premier Partners, K2 Investment Partners, and Johnson & Johnson Innovation.
In what companies Company K Partners invested in?Company K Partners invested in XCENA, Upstage, WIRobotics, CHAI, Mobilint, HyperAccel, Banksalad, Rainist, Curocell, Prazer Therapeutics, Rapport Labs, OncXerna Therapeutics, RIDI, Kmong, Balaan, J2H Biotech, Jaranda, Catch Table, Mediquitous, KoBioLabs, and 89 other companies.

See public comps similar to Company K Partners

Lists including Company K Partners

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial